KALA BIO, Inc. - KALA
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$335K
QoQ value delta ($000)
-$1.234M
(-78.65%)
Implied price effect (QoQ)
-66.15%
Shares
Total shares
1,791,918
QoQ shares delta
-1,048,655
(-36.92%)
Total shares held by funds (by quarter)
Market chart (KALA)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 30 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 72 | 417,517 | 0.0% |
| VANGUARD GROUP INC | 50 | 91,009 | 0.0% |
| CITADEL ADVISORS LLC | 48 | 281,650 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 45 | 261,061 | 0.0% |
| Virtu Financial LLC | 26 | 152,197 | 0.0% |
| ADAR1 Capital Management, LLC | 24 | 141,480 | 0.0% |
| GSA CAPITAL PARTNERS LLP | 15 | 84,470 | 0.0% |
| UBS Group AG | 11 | 66,871 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 10 | 60,549 | 0.0% |
| JANE STREET GROUP, LLC | 6 | 36,000 | 0.0% |
| JPMORGAN CHASE & CO | 5 | 30,017 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 5 | 29,628 | 0.0% |
| STATE STREET CORP | 4 | 28,576 | 0.0% |
| Greenwich Wealth Management LLC | 3 | 18,393 | 0.0% |
| Grant Private Wealth Management Inc | 3 | 20,000 | 0.0% |
| StoneX Group Inc. | 2 | 12,984 | 0.0% |
| GOLDMAN SACHS GROUP INC | 2 | 14,048 | 0.0% |
| LPL Financial LLC | 2 | 17,229 | 0.0% |
| NORTHERN TRUST CORP | 1 | 11,524 | 0.0% |
| BlackRock, Inc. | 1 | 10,809 | 0.0% |
| MORGAN STANLEY | 0 | 2,941 | 0.0% |
| MAI Capital Management | 0 | 300 | 0.0% |
| Cheviot Value Management, LLC | 0 | 153 | 0.0% |
| Parallel Advisors, LLC | 0 | 1 | 0.0% |
| Steward Partners Investment Advisory, LLC | 0 | 120 | 0.0% |